Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2023-11-09 Declaration of Voting R…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
代重要子公司Alvogen Korea Co., Ltd.公告 股東臨時會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a brief announcement from a company about the important resolutions made at a shareholders' extraordinary meeting (股東臨時會) of its important subsidiary, specifically the election of directors. It is not a full report but a notification of meeting results. The key phrase '重要決議事項' (important resolutions) and the context of a shareholders' meeting indicate this is a Declaration of Voting Results & Voting Rights Announcement. The document length is short and it reports on voting outcomes, fitting the DVA category.
2023-11-09 Chinese
代重要子公司Alvogen Korea Co., Ltd.公告 召開股東臨時會
Board/Management Information Classification · 95% confidence The document is a short announcement (718 characters) from a company (美時) regarding the convening of an extraordinary shareholders meeting for its important subsidiary Alvogen Korea Co., Ltd. It includes details such as the board resolution date, meeting date, location, and agenda items, specifically the election of directors. There are no financial statements, detailed reports, or presentations included. The document is an official announcement about a shareholders meeting and related board matters, not a full report or detailed filing. Given the content and length, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management, including election of directors at meetings.
2023-11-09 Chinese
112年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first three quarters of the fiscal year 112 (which corresponds to 2023 in the ROC calendar). It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, unrealized gains/losses on financial assets, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented in a tabular format with comparative figures for the current period and the same period last year. The document length is 4441 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The content is consistent with an Interim / Quarterly Report (IR) because it covers a period shorter than a full fiscal year and provides actual financial statements and analysis. There is no indication that this is a full Annual Report (10-K), audit report, or other types of filings. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). 9M 2023
2023-11-09 Chinese
112年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the third quarter of the fiscal year 112 (which corresponds to 2023 in the Taiwanese calendar). It includes comprehensive financial data such as cash flows from operating, investing, and financing activities, with specific monetary amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3096 characters, which is sufficient to contain detailed financial data rather than just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-11-09 Chinese
112年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the third quarter and nine months of the fiscal year 112 (Taiwan calendar year), including revenue, costs, expenses, profit, and earnings per share. The presence of actual financial figures and analysis for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3695 characters, which is sufficient to contain substantive financial data, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-11-09 Chinese
112年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 112年09月30日 (which corresponds to 2023 Q3) and prior periods. It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, and equity. The presence of actual financial figures and detailed accounting items indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 4398 characters, which is relatively short but sufficient for a quarterly financial report in this context. The content corresponds to a quarterly or interim financial report rather than a full annual report or other filing types. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). Q3 2023
2023-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.